Jules Gouron

Sep 23, 2024 | biorxiv.org | Sahar Emami Naeini |Bidhan Bhandari |Hannah Rogers |Jules Gouron

AbstractDiabetes continues to challenge healthcare system as one of the most growing epidemics with staggering economic burden. It is estimated that 783 million by 2045 will live with diabetes worldwide, 90% of those cases are type 2 diabetes (T2D). T2D is a multifaceted disease, its treatment requires a holistic approach, beyond single target medications with high efficacy. There is a dire need to explore and invent new and effective therapeutic modalities for T2D.

Jun 11, 2024 | biorxiv.org | Sahar Emami Naeini |Bidhan Bhandari |Hannah Rogers |Jules Gouron

AbstractDiabetes continues to challenge healthcare system as one of the most growing epidemics with staggering economic burden. It is estimated that 783 million by 2045 will live with diabetes worldwide, 90% of those cases are type 2 diabetes (T2D). T2D is a multifaceted disease, its treatment requires a holistic approach, beyond single target medications with high efficacy. There is a dire need to explore and invent new and effective therapeutic modalities for T2D.

Jun 4, 2024 | biorxiv.org | Sahar Emami Naeini |Bidhan Bhandari |Hannah Rogers |Jules Gouron

AbstractIntroduction: Diabetes continues to challenge healthcare system as one of the most growing epidemics with staggering economic burden. It is estimated that 783 million by 2045 will live with diabetes worldwide, 90% of those cases are type 2 diabetes (T2D). T2D is a multifaceted disease, its treatment requires a holistic approach with wide range and impactful efficacy.